DK1920248T3 - Clostridialt-toksin-aktivitetsassays - Google Patents

Clostridialt-toksin-aktivitetsassays

Info

Publication number
DK1920248T3
DK1920248T3 DK06851224.3T DK06851224T DK1920248T3 DK 1920248 T3 DK1920248 T3 DK 1920248T3 DK 06851224 T DK06851224 T DK 06851224T DK 1920248 T3 DK1920248 T3 DK 1920248T3
Authority
DK
Denmark
Prior art keywords
clostridial toxin
toxin activity
activity assays
cleavage site
fluorescent member
Prior art date
Application number
DK06851224.3T
Other languages
English (en)
Inventor
Ester Fernandez-Salas
Lanoe E Steward
Kei Roger Aoki
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38829390&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1920248(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK1920248T3 publication Critical patent/DK1920248T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Optical Filters (AREA)
  • Led Devices (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
DK06851224.3T 2005-04-05 2006-04-04 Clostridialt-toksin-aktivitetsassays DK1920248T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66890905P 2005-04-05 2005-04-05
PCT/US2006/012825 WO2008036060A2 (en) 2005-04-05 2006-04-04 Clostridial toxin activity assays

Publications (1)

Publication Number Publication Date
DK1920248T3 true DK1920248T3 (da) 2010-12-13

Family

ID=38829390

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06851224.3T DK1920248T3 (da) 2005-04-05 2006-04-04 Clostridialt-toksin-aktivitetsassays

Country Status (9)

Country Link
US (1) US8067231B2 (da)
EP (2) EP2264458A1 (da)
AT (1) ATE483158T1 (da)
AU (1) AU2006340711C1 (da)
CA (1) CA2605160A1 (da)
DE (1) DE602006017237D1 (da)
DK (1) DK1920248T3 (da)
ES (1) ES2351942T3 (da)
WO (1) WO2008036060A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
AU2003304419A1 (en) * 2002-10-31 2005-03-07 Wisconsin Alumni Research Foundation Botulinum neurotoxin b receptors and use thereof
KR101609894B1 (ko) 2008-03-14 2016-04-08 알러간, 인코포레이티드 면역-기반 보툴리눔 독소 세로타입 ａ 활성 검정
KR101604515B1 (ko) * 2008-03-14 2016-03-17 알러간, 인코포레이티드 면역-기반 보툴리눔 독소 세로타입 ａ 활성 검정
WO2010014608A1 (en) * 2008-07-28 2010-02-04 University Of Louisville Research Foundation, Inc. Methods and compositions for inhibition of neutrophil exocytosis
ES2689703T3 (es) 2009-03-13 2018-11-15 Allergan, Inc. Células útiles para ensayos de actividad de serotipo A de toxina botulínica basados en la respuesta inmunológica
US10908146B2 (en) 2011-06-01 2021-02-02 Biomadison, Inc. Compositions and methods for improving sensitivity in cell based assays
US9303285B2 (en) 2012-01-04 2016-04-05 Biomadison, Inc. Methods and compounds for increasing sensitivity of botulinum assays
US11325954B2 (en) 2011-06-01 2022-05-10 Biomadison, Inc. Compositions and methods for stability testing of botulinum toxin
CN107475293A (zh) 2011-06-01 2017-12-15 拜奥麦迪逊公司 非‑fret肉毒梭菌测定法
CA2857998C (en) * 2011-12-09 2021-01-19 Institut Pasteur Multiplex immuno screening assay
EP3279335B1 (en) 2011-12-31 2021-03-10 Allergan, Inc. Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-a
KR102059091B1 (ko) 2012-01-04 2019-12-24 바이오메디슨, 인코퍼레이티드 보툴리눔 분석 감도를 증진시키기 위한 방법 및 화합물
BR112015022176A8 (pt) 2013-03-13 2019-11-26 Tahoe Institute For Rural Health Res Llc monitor de contagem de glóbulos sanguíneos portátil
JP6636919B2 (ja) * 2013-10-25 2020-01-29 バイオマジソン・インコーポレイテッドＢｉｏｍａｄｉｓｏｎ， Ｉｎｃ． 二重蛍光体を用いた酵素アッセイ
US10408837B2 (en) 2013-12-09 2019-09-10 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Peptide substrates recognizable by type E botulinum neurotoxin
CN105535975B (zh) * 2015-12-21 2018-05-18 中国人民解放军第二军医大学 囊泡相关膜蛋白1在防治肠道病毒71型感染中的应用
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
AU2018389121A1 (en) 2017-12-20 2020-07-30 Allergan, Inc. Botulinum toxin cell binding domain polypeptides and methods of use for treatments of fibrosis associated disorders
CN116693638B (zh) * 2023-05-15 2024-03-08 西北农林科技大学 Pg1-lc蛋白作为snap-25的水解酶的应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652122A (en) 1989-12-21 1997-07-29 Frankel; Alan Nucleic acids encoding and methods of making tat-derived transport polypeptides
US5804604A (en) 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
ATE220421T1 (de) 1990-02-26 2002-07-15 Univ Leland Stanford Junior Identifizierung und expression von insekten- steroidrezeptor-dns-sequenzen
DE69334150T2 (de) 1992-05-14 2008-03-13 Baylor College Of Medicine, Houston Mutierte steroidhormonrezeptoren, methoden für ihre benutzung und molekularer schalter für gentherapie
US5364791A (en) 1992-05-14 1994-11-15 Elisabetta Vegeto Progesterone receptor having C. terminal hormone binding domain truncations
ES2341140T3 (es) 1993-06-10 2010-06-15 Allergan, Inc. Tratamiento de trastornos y afecciones neuromusculares con un seropositivo botulinico diferente.
ES2194025T3 (es) 1993-06-10 2003-11-16 Allergan Inc Toxinas botulinicas multiples para tratar trastornos y enfermedades neuromusculares.
US5464758A (en) 1993-06-14 1995-11-07 Gossen; Manfred Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US5814618A (en) 1993-06-14 1998-09-29 Basf Aktiengesellschaft Methods for regulating gene expression
US6974578B1 (en) 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5962637A (en) 1994-06-03 1999-10-05 Microbiological Research Authority Toxin assay
US6495518B1 (en) 1994-06-13 2002-12-17 Vanderbilt University Method for importing biologically active molecules into cells
US5807746A (en) 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
US5795737A (en) 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US5625048A (en) 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
JPH11510386A (ja) 1995-07-28 1999-09-14 マリー キュリー キャンサー ケア 輸送蛋白質およびそれらの使用
FR2739621B1 (fr) 1995-10-05 1997-12-05 Centre Nat Rech Scient Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
US5804387A (en) 1996-02-01 1998-09-08 The Board Of Trustees Of The Leland Stanford Junior University FACS-optimized mutants of the green fluorescent protein (GFP)
US6072041A (en) 1996-06-03 2000-06-06 Case Western Reserve University Fusion proteins for protein delivery
US6124128A (en) 1996-08-16 2000-09-26 The Regents Of The University Of California Long wavelength engineered fluorescent proteins
US5965699A (en) * 1996-11-06 1999-10-12 The United States Of America As Represented By The Secretary Of The Army Assay for the proteolytic activity of serotype a from clostridium botulinum
US6017735A (en) 1997-01-23 2000-01-25 Marie Curie Cancer Care Materials and methods for intracellular transport and their uses
IL132941A0 (en) 1997-05-21 2001-03-19 Univ Leland Stanford Junior Composition and method for enhancing transport across biological membranes
US6248558B1 (en) 1998-03-31 2001-06-19 Vanderbilt University Sequence and method for genetic engineering of proteins with cell membrane translocating activity
JP2002512808A (ja) 1998-04-28 2002-05-08 ワシントン ユニバーシティー 融合タンパク質の形質導入法
US7090976B2 (en) * 1999-11-10 2006-08-15 Rigel Pharmaceuticals, Inc. Methods and compositions comprising Renilla GFP
US6140132A (en) 1998-06-09 2000-10-31 The Regents Of The University Of California Fluorescent protein sensors for measuring the pH of a biological sample
CA2354044A1 (en) 1998-12-10 2000-06-15 Washington University Protein transduction system and methods of use thereof
EP1157275A4 (en) 1999-02-28 2003-01-15 Univ Washington NEW TRANSDUCTION MOLECULES AND METHOD FOR USING THE SAME
US6767544B2 (en) 2002-04-01 2004-07-27 Allergan, Inc. Methods for treating cardiovascular diseases with botulinum toxin
GB9930519D0 (en) 1999-12-24 2000-02-16 Phogen Limited Uses of transport proteins
US6464986B1 (en) 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
FR2809733B1 (fr) 2000-06-02 2004-04-30 Inst Nat Sante Rech Med Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants
US20040219619A1 (en) 2000-07-21 2004-11-04 Ester Fernandez-Salas Methods of identifying compounds that alter toxin persistence and/or protease activity
US6841535B2 (en) 2000-07-31 2005-01-11 Active Motif Peptide-mediated transfection agents and methods of use
DE60131468D1 (de) 2000-09-25 2007-12-27 U S Medical Res Inst Of Infect Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen
US6423319B1 (en) 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
US7349691B2 (en) 2001-07-03 2008-03-25 Microsoft Corporation System and apparatus for performing broadcast and localcast communications
US7208285B2 (en) 2001-08-28 2007-04-24 Allergan, Inc. Fret protease assays for botulinum serotype A/E toxins
US7332567B2 (en) 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US7374896B2 (en) * 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
US20060063221A1 (en) * 2004-09-21 2006-03-23 Williams Dudley J Lanthanide-based substrates and methods for determining clostridial toxin activity
JP4423851B2 (ja) 2002-02-28 2010-03-03 日本精工株式会社 直動案内装置の製造方法
US6921538B2 (en) 2002-05-10 2005-07-26 Allergan, Inc. Therapeutic treatments for neuropsychiatric disorders
WO2004033355A1 (de) * 2002-09-13 2004-04-22 Otis Elevator Company Sicherheitsüberwachung für personenbeförderer
US7183066B2 (en) 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
AU2003272800A1 (en) * 2002-10-01 2004-04-23 University Of Maryland Methods for identifying inhibitors of botulinum neurotoxins
US7166692B2 (en) 2003-03-04 2007-01-23 Canbrex Bio Science Walkersville, Inc. Intracellular delivery of small molecules, proteins, and nucleic acids
EP1751284A4 (en) * 2003-12-19 2010-01-13 Wisconsin Alumni Res Found METHOD AND COMPOSITIONS FOR DETECTING BOTULINUM NEUROTOXINE
CA2565678C (fr) 2004-05-05 2013-07-09 Pharmaleads Substrats peptidiques reconnus par la toxine botulique de type a, bont/a et leurs utilisations
US7399607B2 (en) 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity

Also Published As

Publication number Publication date
US20090191583A1 (en) 2009-07-30
WO2008036060A2 (en) 2008-03-27
EP1920248B1 (en) 2010-09-29
US8067231B2 (en) 2011-11-29
EP2264458A1 (en) 2010-12-22
AU2006340711B2 (en) 2012-02-23
WO2008036060A3 (en) 2008-09-12
CA2605160A1 (en) 2006-10-05
AU2006340711C1 (en) 2013-02-07
EP1920248A2 (en) 2008-05-14
AU2006340711A8 (en) 2008-08-07
AU2006340711A1 (en) 2007-11-15
ATE483158T1 (de) 2010-10-15
ES2351942T3 (es) 2011-02-14
DE602006017237D1 (en) 2010-11-11

Similar Documents

Publication Publication Date Title
DK1920248T3 (da) Clostridialt-toksin-aktivitetsassays
DE602006014812D1 (de) Lostridientoxinaktivität
EP1903478A3 (en) Methods and systems for defining, identifying and learning geometric features
BRPI0510674A (pt) variantes fc otimizadas
ITRM20040447A1 (it) Sistema di fornitura di seminari interattivi, e relativo metodo.
BRPI0812878B8 (pt) anticorpo isolado ou parte funcional do mesmo, vetor, método para produzir um anticorpo ou uma parte funcional do mesmo, para produzir uma célula produtora de anticorpo e para produzir um anticorpo capaz de se ligar especificamente a rsv, composição, e, uso de um anticorpo ou parte funcional do mesmo ou de uma composição ou de vetor
ATE462783T1 (de) Variante foki-spaltungshälften-domänen
WO2006135904A3 (en) Method for producing improved results for applications which directly or indirectly utilize gene expression assay results
NO20044051L (no) Analyse for ACTRIIB-kinase aktivitet
EA200702193A1 (ru) Гликозилирование белков
CY1113816T1 (el) Μορια ταυτοποιησης τα οποια ρυθμιζουν τις αλληλεπιδρασεις πρωτεϊνης-πρωτεϊνης με τη χρηση ανταποκριτων που ενεργοποιουνται με μια πρωτεαση
NO20064715L (no) Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C)
WO2006107611A3 (en) Detection of an immune response to gdf-8 modulating agents
WO2007094752A3 (en) Biobriefcase
ATE460487T1 (de) Screening-test für ribosomale antibiotika
WO2005103229A3 (en) Transgenomic mitochondria, transmitochondrial cells and organisms, and methods of making and using
WO2006074464A3 (en) Modulating toll-like receptor activity
NO20052553D0 (no) Cobalaminanalyse.
WO2005094441A3 (en) Split enzyme linked immunosorbent and nucleic acid assays
WO2006091672A3 (en) Novel assays utilizing nicotinic acetylcholine receptor subunits
WO2008143702A3 (en) Anti-mrp3 antibodies and methods of use
NO20090326L (no) DNA fragmenteringsanalyse
DK1838851T3 (da) Fremgangsmåde til polypeptidmutagenese
WO2007126415A3 (en) Novel compositions and methods for promoting, inhibiting, and detecting protein entry into cells
WO2008149088A8 (en) Melanoma assay and antigens